Effect of sodium-glucose cotransporter-2 inhibitor (SGLT2-i) in patients with LVAD: a systematic review and meta-analysis

被引：0
|
作者：
Hasabo, E. A. [1 ,2 ]
Isik, B. [3 ]
Elgadi, A. [4 ]
Eljack, M. M. F. [5 ]
Yacuob, M. S. [1 ,2 ]
Alzomor, H. [1 ,2 ]
Sawabi, R. [1 ,2 ]
Sultan, S. [6 ]
Caliskan, K. [7 ]
Soliman, O. [1 ,2 ]
机构：
[1] Univ Galway, CORRIB Core Lab, Galway, Ireland
[2] Galway Univ Hosp, Galway, Ireland
[3] Univ Limerick, Limerick, Ireland
[4] Univ Khartoum, Fac Med, Khartoum, Sudan
[5] Univ Bakht Alruda, Fac Med, Ad Duwaym, Sudan
[6] Univ Coll Hosp, Western Vasc Inst, Galway, Ireland
[7] Erasmus MC, Rotterdam, Netherlands
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.3355
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Stroke safety with Sodium-Glucose Cotransporter-2 (SGLT-2) inhibitor use: a systematic review and meta-analysis
    Roddick, A. J.
    Zheng, S. L.
    DIABETOLOGIA, 2018, 61 : S308 - S308
  • [2] Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis
    Zhang, Nan
    Wang, Yueying
    Tse, Gary
    Korantzopoulos, Panagiotis
    Letsas, Konstantinos P.
    Zhang, Qingpeng
    Li, Guangping
    Lip, Gregory Y. H.
    Liu, Tong
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 28 (17) : 1961 - 1973
  • [3] Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure A Systematic Review and Meta-analysis
    Zou, Xinyu
    Shi, Qingyang
    Vandvik, Per Olav
    Guyatt, Gordon
    Lang, Chim C.
    Parpia, Sameer
    Wang, Si
    Agarwal, Arnav
    Zhou, Yiling
    Zhu, Ye
    Tian, Haoming
    Zhu, Zhiming
    Li, Sheyu
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (06) : 851 - +
  • [4] Heart Failure Prognosis in Diabetic Patients on SGLT2 (Sodium-Glucose Cotransporter-2) Inhibitors: A Systematic Review and Meta-Analysis
    Nso, Nso
    Emmanuel, Kelechi
    Nassar, Mahmoud
    Ayinde, Hakeem
    CIRCULATION, 2021, 144
  • [5] Assessing the Effect of Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i) on Outcomes in Patients With Acute Myocardial Infarction: A Systematic Review and Meta-Analysis
    Nall, Scott
    Rawat, Anurag
    Gill, Fahad Shaukat
    Saleem, Rushna
    Saeed, Simran
    Ahmed, Saeed
    Wei, Calvin R.
    Allahwala, Danish
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [6] Efficacy and safety of SGLT2-i in patients using LVAD: a systematic review and meta-analysis
    Hasabo, E. A.
    Isik, B.
    Elgadi, A.
    Yacoub, M. S.
    Elzomor, H.
    Sawabi, R.
    Eljack, M. M. F.
    Sultan, S.
    Caliskan, K.
    Soliman, O.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 594 - 594
  • [7] Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors: A Systematic Review and Meta-analysis
    Alexander, Jason
    Staab, Erin M.
    Wan, Wen
    Franco, Melissa
    Knitter, Alexandra C.
    Thomas, Celeste C.
    Press, Valerie G.
    Zeytinoglu, Meltem
    Skandari, Reza
    Gunter, Kathryn E.
    Bindon, Brittany
    Jumani, Sanjay
    Bolen, Shari D.
    Maruthur, Nisa M.
    Huang, Elbert
    Philipson, Louis H.
    Laiteerapong, Neda
    DIABETES, 2020, 69
  • [8] SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR (SGLT2I) USE IN PATIENTS WITH FONTAN CIRCULATION
    Brenzel, Thomas
    Gaydos, Stephanie
    McHugh, Kimberly E.
    Woodard, Frances Kline
    Savage, Andrew
    Gregg, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1653 - 1653
  • [9] Effects of sodium-glucose cotransporter-2 inhibitors in myocardial infarction patients: A systematic review and meta-analysis
    Jia, Qiufeng
    Zuo, Ankai
    Song, Hui
    Zhang, Chengrui
    Fu, Xiangrui
    Hu, Keqing
    An, Fengshuang
    DIABETES OBESITY & METABOLISM, 2025, 27 (03): : 1276 - 1286
  • [10] Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis
    Li, Hang-Long
    Lip, Gregory-Y H.
    Feng, Qi
    Fei, Yue
    Tse, Yi-Kei
    Wu, Mei-Zhen
    Ren, Qing-Wen
    Tse, Hung-Fat
    Cheung, Bernard-M Y.
    Yiu, Kai-Hang
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
12345